PRODUCTS

Home > Products > Formulation
Formulation

Finished Products-Worldwide Submission and Marketing

Product Name

Standard

Strength

Packing Size

Status

Amlodipine besylate

Film-coated tablet

USP

2.5/5/10mg

90s x 1

Global marketing

In-house

5/10mg

10s x 1

Azithromycin 1H2O

Film-coated tablet

USP

250/500/600mg

30s x 1

US under review

Azithromycin 2H2O

Film-coated tablet

In-house

250mg

500mg

6s x 1

3s x 1

Global marketing

Ciprofloxacin

Film-coated tablet

In-house

100/250/500/750mg

10s x 1

Global marketing

Clarithromycin

Film-coated tablet

USP

250mg/500mg

60s x 1

Global marketing

In-house

250mg

500mg

5s x3

7sx2/6, 10sx2

Clarithromycin

Extended-release  tablet

USP

500mg

10s x 1

Global marketing

In-house

500mg

10s x 1/2/10

Entacapone

Film-coated tablet

USP

200mg

60s x 1

Global marketing

In-house

200mg

30s x 1

Esomeprazole Magnesium Delayed-release Capsules

USP

In-house

20/40mg

60s x 1

EU approving in 2017

Fingolimod Capsules

In-house

0.5mg

7s x 1/4

US Under review

Ibuprofen

Film-coated  tablet

USP

400/600/800mg

100/60/50s x 1

US Under review

Irbesartan

Film-coated  tablet

USP  

75/150

300mg

30/90s x 1

30s x 1

Global marketing

In-house

75/150/300mg

6s x 1

Levofloxacin

Film-coated  tablet

USP

250/500/750mg

50/50/20s x 1

Global marketing

In-house

250/500mg

6/10s x 1

Linagliptin  Tablets

In-house

5mg

30s x 1

US Under review

Linagliptin and Metformin  Hydrochloride Tablets

In-house

2.5mg/500mg 

2.5mg/850mg

2.5mg/1000mg

60s x 1

US Under review

Metformin tablets

USP

500/850/1000

1000s x 1

US Under review

Moxifloxacin HCl

Film-coated  tablet

USP

400mg

30s x 1

Global marketing

In-house

400mg

10s x 1

Sitagliptin and Metformin Film-coated  tablet

In-house

50/850mg; 50/1000mg

14/60 x 1

EU approving in 2017

Olanzapine

Film-coated  tablet

USP

2.5/5/7.5/10/15/20mg

30s x 1

Global marketing

In-house

2.5/5/7.5/10/15/20mg

7/10s x 1

Olanzapine

Orally  Disintegrating Tablets

USP

5/10/15/20mg

30s x 1

Global marketing

In-house

5/10/15/20mg

10s x 1

Olmesartan medoxomil

tablets

In-house

10 /20 /40 mg

7/10s x 1

EU approving in 2017

Prasugrel HCl

Film-coated  tablet

In-house

5/10mg

30s x 1

US Under review

Rivaroxaban Tablets

In-house

10/15/20mg

30s x 1, 90s x 1

US Under review

Simvastatin

Film-coated tablet

USP

5/10/20/40/80mg

30s x 1

US Under review

Ticagrelor  Tablets

In-house

90mg

60s x 1

US Under review

Zidovudine

Film-coated  tablet

USP

300mg

60s x 1

Global marketing


Approvedand submitted to Chinese CFDA

Product Name

Dosage Form

Standard

Strength

Packing Size

Status

Azithromycin

Capsules

CP

250 mg

6s × 1/2

Marketed

Azithromycin

Dispersible Tablets

CP

250 mg

6s × 1/2

Marketed

Azithromycin

Suspension

CP

100 mg

6s, 8s, 12s

Marketed

Amlodipine besylate

Tablets

CP

5 mg

7s, 14s, 28s

Marketed

Benzbromarone

Tablets

CP

50 mg

10s

Marketed

Cetirizine Hydrochloride

Dispersible Tablets

CP

10 mg

6s × 1/2/4

Marketed

Clarithromycin

Dispersible Tablets

CP

250 mg

6s

Marketed

Clarithromycin

Tablets

CP

250 mg

6s

Marketed

Fluconazole

Capsules

CP

50 mg

6s, 10s

Marketed

Fudosteine

Tablets

CP

200mg

6s× 2

Marketed

Glipizide

Capsules

CP

5mg

10s × 3

Marketed

Levofloxacin lactate

Tablets

CP

100 mg

10s

Marketed

Lisinopril

Tablets

CP

10 mg

7s × 1/2/4

Marketed

Mycophenolate mofetil

Powder for injection

CP

500mg

2s

Marketed

Oxaprozin

Enteric-coated tablets

CP

200 mg

8s × 1/2/3

Marketed

Ozagrel sodium

Powder for injection

CP

20mg

8s

Marketed

Simvastatin

Tablets

CP

10 mg

10s

Marketed

20 mg

7s × 1/2

Marketed

Telmisartan

Tablets

CP

40 mg,80 mg

7s × 1/2

Marketed

Valacyclovir  Hydrochloride

Tablets

CP

300 mg

6s, 10s

Marketed

 


Copyright  HEC Pharma Co., Ltd